Platelet-rich plasma (PRP) therapy has gained significant traction in regenerative medicine, particularly for its applications in orthopedic treatments. PRP involves the concentration of a patient’s platelets to accelerate the healing of injured tendons, ligaments, muscles, and joints.
The effectiveness of PRP treatments heavily depends on the quality and concentration of the platelets recovered during the preparation process. A recent peer-reviewed study titled “A Retrospective Analysis of a Commercially Available Platelet-Rich Plasma Kit During Clinical Use” sheds light on the high platelet recovery rates achieved using EmCyte PRP kits, providing valuable insights for clinicians and patients alike.
The study, conducted by researchers Meredith H. Prysak PhD, Christopher P. Kyriakides DO, Tyler A. Zukofsky BA, Stefan E. Reutter, Jennifer Cheng PhD, and Gregory E. Lutz MD, offers a detailed analysis of the EmCyte PurePRP II 60-mL preparation kit. The research was a collaborative effort involving institutions such as Orthobond Corporation, Rusk Rehabilitation at NYU Langone Health, Regenerative SportsCare Institute, and the Department of Physiatry at the Hospital for Special Surgery.
The primary objective of the study was to assess whether the EmCyte PurePRP II kit could consistently meet the manufacturer’s expectations for platelet enrichment during routine clinical use. Additionally, the study aimed to determine the impact of varying PRP yield volumes on platelet content. This retrospective review provides critical insights into the real-world performance of the EmCyte PRP kit, bridging the knowledge gap between manufacturer specifications and clinical outcomes.
PRP Preparation Protocols: The study evaluated two specific protocols for PRP preparation using the EmCyte PurePRP II kit:
PRP Yield Volumes: The researchers examined the impact of two different PRP yield volumes:
The study yielded several significant findings regarding the performance of the EmCyte PurePRP II 60-mL preparation kit. Here are the key results:
High Platelet Recovery Rates:
Impact of PRP Yield Volume:
Gender and Age Effects:
Granulocyte Inclusion/Exclusion:
The study’s findings have several important implications for clinical practice:
Validation of EmCyte PurePRP II Kits:
Optimizing PRP Preparation:
Standardization and Quality Control:
Patient-Specific Considerations:
Advancing PRP Research and Practice:
In summary, the retrospective study of the EmCyte PurePRP II 60-mL preparation kit has demonstrated its effectiveness in achieving high platelet recovery rates, meeting and exceeding the manufacturer’s specifications. The findings validate the reliability of the EmCyte PRP kits and highlight the importance of optimizing preparation protocols to ensure consistent and high-quality PRP treatments. Clinicians can confidently use these kits in routine practice, knowing that they deliver the desired platelet concentrations crucial for effective regenerative medicine treatments.
Daniel Zengel, an executive with over 10 years of experience in the pharmaceutical and medical device space, is dedicated to delivering industry-leading, cost-effective products to US-based medical providers. Specializing in regenerative medicine, Daniel focuses on sales, training, and marketing support to help clinics across the country successfully implement platelet-rich plasma (PRP) therapy.
*We Typically Call Within 15 Minutes
Whether you are interested in offering PRP for aesthetic or musculoskeletal indications, we will provide you with everything you need to get great outcomes while increasing revenue!